Indefinite Delivery Contract 36E79720D0070
Award Date
11/15/20
Last Date to Order
11/14/25
Federal Agency
National Acquisition Center
Awardee
Organon LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The contract IDV awarded to Organon LLC is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. The contract, valued at $1.5 million, allows Organon to deliver drugs, pharmaceuticals, and hematology-related products to various federal agencies, including the Department of Veterans Affairs (VA), Defense Health Agency, Bureau of Prisons, and Indian Health Service. The contract supports the VA's Pharmaceutical Prime Vendor program by providing Organon's...
The Department of Veterans Affairs National Acquisition Center has awarded a single-award Indefinite Delivery Contract (IDC) to Organon LLC for Infliximab Injection 100 mg/vial. The $119,538,562.32 contract has a base period of one year and four one-year option periods, running from September 1, 2023 through August 31, 2025. This IDC will provide an uninterrupted supply of the pharmaceutical product to the VA, Bureau of Prisons, and Indian Health Service through the VA's Pharmaceutical Prime...
The Department of Veterans Affairs (VA) National Acquisition Center has awarded Organon LLC a single-award Indefinite Delivery Contract (IDC) valued at $325,063,436.44 to provide Adalimumab pen and syringe kits. The contract has a base year of March 9, 2024 to March 8, 2025, with four one-year option periods, for a total potential period of performance through March 8, 2026. The IDC will support the VA's Pharmaceutical Prime Vendor program, as well as provide Adalimumab products to the Bureau of...
The National Acquisition Center, a civilian agency of the U.S. Department of Veterans Affairs, awarded a single-award Indefinite Delivery Contract (IDC) to TG Therapeutics Inc., a for-profit pharmaceutical manufacturer, to provide ublituximab-XIIY 150mg/6ml injection, an anti-CD20 antibody, for a 1-year base period and four 1-year option periods through June 16, 2026. The $186,776,520 IDC was awarded on June 17, 2024 with the intent to list the awarded product as the preferred agent on the VA...
This federal contract IDV award is for the provision of Bevacizumab injections to support multiple federal healthcare organizations, including the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract was awarded to Pfizer Inc. as the single prime contractor, with a ceiling value of $46,893,140.00 and a total ordering period from August 13, 2025 to August 12, 2026, with four additional one-year...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency, to Pfizer Inc. to provide an uninterrupted supply of Bevacizumab (ZIRABEV) for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a 1-year base period with four 1-year option periods, for a total potential period of performance through August 12, 2025. The contract value has a ceiling of...
The federal government has awarded an Indefinite Delivery Contract to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars, to supply a variety of prescription medications through the VA and DoD pharmaceutical prime vendor programs. The contract, valued up to $164,608.40, has a base year plus four one-year option periods, and aims to meet the medication needs of veterans, active duty military personnel, federal inmates, and Native American populations served by the...
The federal contract indefinite delivery vehicle (IDV) award V797D70114 is a Federal Supply Schedule (FSS) contract held by ONY Biotech Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a ceiling value of $294,760.00 and an ultimate completion date of September 14, 2025. The contracting agency is the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12 (VISN 12). The contract aims to procure pharmaceutical and...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the U.S. Department of Veterans Affairs (VA), to Pfizer Inc. as the prime contractor. The single-award IDC has a ceiling value of $74,038,216.80 and a base ordering period from September 15, 2025 to September 14, 2026, with four one-year option periods. The contract is for the procurement of Rituximab and its biosimilar products to support multiple federal healthcare agencies,...
The U.S. Department of Veterans Affairs (VA) has awarded Sandoz Inc., a Novartis subsidiary, an indefinite delivery vehicle (IDV) under the Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The contract, valued at $16.85 billion, allows the VA, Department of Defense, Bureau of Prisons, and Indian Health Services to order a variety of pharmaceutical products from Sandoz's commercial catalog, including antibiotics, chemotherapy drugs, ophthalmic solutions, psychiatric medications,...